CREDIT AGRICOLE SA 22/05/2024 AGM
1Approve Financial StatementsAbstain
2Approve Consolidated Financial StatementsAbstain
3Approve the DividendFor
4Approve Transactions with Groupe TVA REFor
5Approve Framework Agreement For
6Approve Transfer of Activities of Company's Banking Services Department For
7Approve Caceis Governance RulesFor
8Re-elect Raphael Appert - Vice Chair (Non Executive)Oppose
9Re-elect Olivier Auffray - Non-Executive DirectorOppose
10Re-elect Nicole Gourmelon - Non-Executive DirectorOppose
11Re-elect Marianne Laigneau - Non-Executive DirectorOppose
12Re-elect Louis Tercinier - Non-Executive DirectorOppose
13Elect Christine Gandon - Non-Executive DirectorFor
14Re-elect Christophe Lesur - Employee RepresentativeFor
15Renew Appoint of PwC as AuditorOppose
16Appoint Mazars the Auditors in replacement of Ernst & Young For
17Appoint PwC as the Auditor for the Sustainability Reporting Oppose
18Appoint Mazars as the Auditor for the Sustainability Reporting For
19Approve Remuneration Policy for the Chair of the BoardFor
20Approve Remuneration Policy for the CEO (Philippe Brassac)Abstain
21Approve Remuneration Policy for the Deputy CEO (Olivier Gavalda)Abstain
22Approve Remuneration Policy for the Deputy CEO (Jérôme Grivet)Abstain
23Approve Remuneration Policy for the Deputy CEO (Xavier Musca)Abstain
24Approve Remuneration Policy for DirectorsFor
25Approve the Remuneration Paid to the Chair (Dominique Lefebvre)For
26Approve the Remuneration Paid to the CEO (Philippe Brassac)For
27Approve the Remuneration Paid to the Deputy CEO (Xavier Musca)For
28Approve the Remuneration Paid to the Deputy CEO (Jérôme Grivet)For
29Approve the Remuneration Paid to the Deputy CEO (Olivier Gavalda)For
30Approve the Remuneration ReportFor
31Approve the Aggregate Remuneration Granted in 2023 to Senior Management, Responsible Officers and Regulated Risk-TakersFor
32Authorise Share RepurchaseOppose
33Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 4.6 BillionFor
34Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 908 Million Oppose
35Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 908 Million Oppose
36Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 33-35, 37-38 and 41-42Oppose
37Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in KindFor
38Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive RightsOppose
39Set Total Limit for Capital Increase to Result from All Issuance Requests at EUR 4.6 BillionFor
40Authorize Capitalization of Reserves of Up to EUR 1 Billion for Bonus Issue or Increase in Par ValueFor
41Authorize Capital Issuances for Use in Employee Stock Purchase Plans Oppose
42Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees of the Group's SubsidiariesOppose
43Authorize Decrease in Share Capital via Cancellation of Repurchased SharesFor
44Authorize Filing of Required Documents/Other FormalitiesFor